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Cardiac Magnetic Resonance Assessment
Soon After a First ST-Segment Elevation
Myocardial Infarction
Vicente Bodi, MD,* Juan Sanchis, MD,* Julio Nunez, MD,* Luis Mainar, MD,*
Maria P. Lopez-Lereu, MD,† Jose V. Monmeneu, MD,† Eva Rumiz, MD,*
Fabian Chaustre,* Isabel Trapero,* Oliver Husser, MD,* Maria J. Forteza,*
Francisco J. Chorro, MD,* Angel Llacer, MD*
Valencia, Spain
O B J E C T I V E S To evaluate the prognostic value of a comprehensive cardiac magnetic resonance
(CMR) assessment soon after a ﬁrst ST-segment elevation myocardial infarction (STEMI).
B A C KG ROUND CMR allows for a simultaneous assessment of wall motion abnormalities (WMA),
WMA with low-dose dobutamine (WMA-dobutamine), microvascular obstruction, and transmural
necrosis. This approach has been proven to be useful to predict late systolic recovery soon after STEMI.
Its prognostic value and the relative prognostic weight of these indexes are not well-deﬁned.
METHOD S We studied 214 consecutive patients with a ﬁrst STEMI treated with thrombolytic
therapy or primary angioplasty discharged from hospital. In the ﬁrst week (7  1 day after infarction),
with CMR we determined the extent (number of segments) of WMA, WMA-dobutamine, microvascular
obstruction, and transmural necrosis.
R E S U L T S During a median follow-up of 553 days, 21 major adverse cardiac events (MACE) including
4 cardiac deaths, 6 nonfatal myocardial infarctions, and 11 readmissions for heart failure were
documented. The MACE was associated with a larger extent of WMA (8  4 segments vs. 5  3
segments, p 0.001), WMA-dobutamine (6 4 segments vs. 4 3 segments, p 0.004), microvascular
obstruction (3  3 segments vs. 1  2 segments p 0.001), and transmural necrosis (7  3 segments
vs. 3 3 segments, p 0.001). In a complete multivariate analysis that included baseline characteristics,
electrocardiogram, biomarkers, angiography, ejection fraction, left ventricular volumes, and all CMR
indexes, WMA/segment (hazard ratio: 1.29 [95% conﬁdence interval: 1.11 to 1.49], p  0.001) and the
extent of transmural necrosis/segment (hazard ratio: 1.30 [95% conﬁdence interval: 1.12 to 1.51], p 
0.001) were the only independent prognostic variables.
CONC L U S I O N S A comprehensive CMR assessment is useful for stratifying risk soon after STEMI, but
only the extent of systolic dysfunction and of transmural necrosis provide independent prognostic
information. (J Am Coll Cardiol Img 2009;2:835–42) © 2009 by the American College of Cardiology
Foundation
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836n patients with ST-segment elevation myocardial
infarction (STEMI) discharged from hospital, risk
stratification is a challenge (1). Noninvasive tech-
niques are necessary not only to establish the
robability of systolic recovery (2) but also to
redict risk (3).
See page 843
Soon after STEMI, cardiac magnetic resonance
CMR) allows for a simultaneous state-of-the-art
nalysis of the extent of wall motion abnormalities
WMA) at baseline, WMA with low-dose dobut-
mine (WMA-dobutamine), microvascular ob-
truction and transmural necrosis (2,4). Separately,
ome of these CMR indexes have been proven to
e useful for stratifying risk (5–8), but their rela-
tive prognostic weight once adjusted for
well-established predictors is unknown.
Taking into account that this is a time-
consuming approach and that CMR is not
widely available yet, this issue needs to be
addressed.
The management and risk stratification
of patients with STEMI has to be based
on a complete clinical evaluation and
on an estimation of systolic function (1).
We hypothesized that a comprehensive
assessment of CMR soon after STEMI
can provide independent prognostic in-
formation beyond this traditional and
well-established approach. The relative
value of CMR indexes for predicting out-
come soon after a first STEMI was also
analyzed.
E T H O D S
tudy group. From January 2004 to December 2006,
e prospectively included 250 consecutive patients
dmitted to a tertiary university hospital with a first
TEMI treated with thrombolytic therapy or primary
ngioplasty. The exclusion criteria were as follows:
ontraindications to CMR (n  3), death (n  14),
einfarction (n  5), severe clinical instability (n 
1), and need for cardiac surgery during admission
n  3). Accordingly, the study group comprised 214
atients without serious complications during admis-
ion, discharged from hospital, and in whom CMR
tudies were successfully performed.
The local ethics committee approved the research
rotocol. Informed consent was obtained from all
iac
ion
withubjects. peperfusion therapy. Reperfusion strategy and
edical treatment were left to the discretion of
he attending cardiologists. Thrombolytic agents
ere administered in 125 patients (58%), and 89
42%) were directly submitted to percutaneous
evascularization.
Overall, 198 patients (92%) were treated with a
tent: 89 during primary angioplasty, 23 during
escue angioplasty, and 86 during routine cardiac
atheterization performed after thrombolysis (me-
ian 2 days).
Thrombolysis In Myocardial Infarction (TIMI)
ow grade and myocardial blush grade were deter-
ined offline by an experienced observer unaware of
MR results with the software Integris HM3000
Philips, Best, the Netherlands). A TIMI flow
rade 3 and myocardial blush grade 2 to 3 were
egarded as normal (9).
aseline characteristics, electrocardiogram, and blood
amples. Baseline characteristics and clinical data
ere recorded in all cases. The TIMI risk score for
TEMI was calculated in all patients as a surrogate
f baseline clinical risk (10). The percentage of sum
T-segment resolution 90 min after reperfusion
herapy was determined. Peak troponin I was
ssessed.
MR. CMR (1.5-T scanner, Sonata Magnetom,
iemens, Erlangen, Germany) was performed 7 1
ay (at least 48 h after cardiac catheterization) after
TEMI in accordance with our laboratory protocol
2,8,11). All images were acquired by a phased-
rray body surface coil during breath-holds and
ere electrocardiogram (ECG)-triggered.
Cine images were acquired at rest and during
ntravenous infusion of low-dose (10 g/kg/min)
obutamine in 2-, 3-, and 4-chamber views and
very 1 cm in short-axis views with steady-state free
recession imaging sequences (repetition time/echo
ime: 3.2/1.6 ms; flip angle: 61°; matrix: 256 128;
lice thickness: 6 mm; temporal resolution: 26 ms).
Delayed enhancement imaging was performed in
he same projections used for cine images at least 10
in after administering 0.1 mmol/kg of gadolinium-
iethylenetriaminepentaacetic acid (Magnograf, Juste
.A.Q.F., Madrid, Spain). A segmented inversion
ecovery steady-state free precession imaging sequence
as used (repetition time/echo time: 2.5/1.1 ms; slice
hickness: 6 mm; flip angle: 50°; matrix: 195  192)
ullifying myocardial signal.
MR data analysis. The CMR studies were analyzed
ffline by an experienced observer blinded to allB B R E V I A T I O N S
N D A C R O N YM S
I confidence interval
MR cardiac magnetic
esonance
CG electrocardiogram
R hazard ratio
ACEmajor adverse card
vents
TEMI ST-segment elevat
yocardial infarction
IMI Thrombolysis In
yocardial Infarction
MAwall motion
bnormalities
MA-dobutamineWMAatient data with customized software (QMASS
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837R 6.1.5, Medis, Leiden, the Netherlands). The
7-segment model was applied (12).
End-diastolic volume index (ml/m2), end-
ystolic volume index (ml/m2), ejection fraction
%), ejection fraction with low-dose dobutamine
%), and left ventricular mass (g/m2) were quanti-
ed by manual definition of endocardial and epi-
ardial borders of all short-axis slices in cine images.
Four CMR indexes were determined (Fig. 1).
he criteria used to define abnormal results on a
egmental basis were based on validated definitions
4,7,13) and on our previous data to predict late
ystolic recovery (2,14).
On a patient basis, the extent of each index was
efined as the number of segments displaying ab-
ormal results (4,8,14). The cutoff values used to
onsider “significant” abnormalities were estab-
ished on the basis of the receiver-operating char-
cteristics curves for predicting major adverse car-
iac events (MACE).
MA. On a segmental basis wall thickening was
uantitatively assessed in all segments in cine se-
uences at rest and abnormal wall thickening (end-
ystolic thickness  end-diastolic thickness, mm)
as considered if 2 mm. On a patient basis,
ignificant WMA was considered if abnormal wall-
hickening was present in 5 segments.
MA-DOBUTAMINE. On a segmental basis abnor-
al wall thickening was considered if 2 mm. On
patient basis, significant WMA-dobutamine was
onsidered if abnormal wall thickening was present
n 5 segments.
ICROVASCULAR OBSTRUCTION. On a segmental
asis this index was visually defined in delayed
Figure 1. Cardiac Magnetic Resonance Indexes Analyzed
Example of a patient with a large anterior myocardial infarction. (Le
Signiﬁcant improvement with low-dose dobutamine (arrow) in the
area of necrosis in the mid ventricular area (arrow). WMA  wall mnhancement sequences as a lack of contrast uptake tn the core of a segment surrounded by tissue
howing delayed enhancement. On a patient basis,
ignificant microvascular obstruction was consid-
red if it was detected in at least 1 segment.
XTENT OF TRANSMURAL NECROSIS. On a seg-
ental basis, transmural necrosis was quantitatively
onsidered when 50% of the myocardial wall
howed signal intensity 2 SD in comparison with
remote noninfarcted area. On a patient basis,
ignificant extent of transmural necrosis was con-
idered if it was detected in 4 segments. The
ercentage of left ventricular mass showing delayed
nhancement was also calculated and used as a
urrogate of infarct size.
In our laboratory, in a series of 50 patients (850
egments) with STEMI, the interobserver variabil-
ty with respect to all indexes evaluated was 5%.
nd point and follow-up. The end point was MACE
nd included cardiac death, admission for nonfatal
yocardial infarction (15), and admission for heart
ailure (16) whichever occurred first. All MACE
ere reviewed, and consensus between 3 cardiolo-
ists was required to finally designate a MACE.
tatistical analysis. Continuous data were expressed
s the mean  SD and were compared by the
npaired t test. Proportions were compared by the
hi-square statistic; the Fisher exact test was used
hen appropriate. Survival distributions for the
ime to event were estimated with the Kaplan-
eier method and the log-rank test.
The association of variables with MACE was
ssessed with the Cox proportional hazard regres-
ion model with stepwise multivariate procedures.
ariables with a p value 0.2 in the univariate
nalyses along with traditional risk factors were
bnormal wall motion at rest in the apical area (arrow). (Middle)
e area. (Right) Microvascular obstruction in the core of a large
n abnormalities.ft) A
samested in multivariate procedures. A significance of
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838.05 was required for a variable to be included in the
nal multivariate model. Hazard ratios (HRs) with
he corresponding 95% confidence intervals (CIs)
ere estimated. The ability of variables to predict
ACE was also assessed by estimating the Har-
ell’s C-statistic.
Statistical significance was considered for p 0.05.
he software SPSS version 11.0 (SPSS Inc., Chicago,
llinois) and STATA version 9.0 (Stata Corp., Col-
ege Station, Texas) were used throughout.
E S U L T S
uring a median follow-up of 553 days (range 280 to
,092 days), 21 first MACE including 4 cardiac
eaths, 6 nonfatal myocardial infarctions, and 11
Table 1. Characteristics of the Whole Study Group and of Patie
Study Group
(n  214)
Baseline characteristics
Age (yrs) 57 12
Male sex (%) 180 (84)
Diabetes (%) 35 (16)
Hypertension (%) 87 (41)
Hypercholesterolemia (%) 79 (37)
Smoker (%) 135 (63)
Anterior infarction (%) 123 (58)
Heart rate (beats/min) 81 21
Systolic pressure (mm Hg) 125 24
Killip class 1 0.3
Time to reperfusion therapy (min) 239 180
TIMI risk score 3 2
Biomarkers and ECG
Peak troponin I (ng/ml) 72 71
Glucose (mg/l) 133 60
Creatinine (mg/l) 1 1
ST-segment resolution (%) 73 25
Cardiac catheterization
Proximal left anterior descending (%) 56 (26)
Multivessel disease (%) 51 (24)
Primary angioplasty (%) 89 (42)
TIMI ﬂow grade 3 (%) 198 (93)
Myocardial blush grade 2–3 (%) 162 (76)
Medical treatment
Thrombolysis (%) 125 (58)
IIb/IIIa inhibitors (%) 85 (40)
Beta-blockers (%) 141 (66)
ACE inhibitors (%) 128 (60)
Statins (%) 175 (82)
Diuretics (%) 25 (12)
ACE  angiotensin-converting enzyme; ECG  electrocardiogram; MACE  maeadmissions for heart failure were detected. cBaseline characteristics, ECG, biochemical, and
ardiac catheterization variables associated with
ACE are displayed in Table 1.
rognostic value of CMR. UNIVARIATE ANALYSIS. In
he univariate analysis, patients with MACE showed
more depressed ejection fraction, a lower ejection
raction with low-dose dobutamine, a larger end-
ystolic volume index, more left ventricular mass, a
arger infarct size, and a trend toward a larger end-
iastolic volume index. Similarly, patients with MACE
isplayed a larger extent of the 4 CMR indexes
valuated: WMA, WMA-dobutamine, microvascular
bstruction, and transmural necrosis (Table 2).
Significant WMA was detected in 89 patients
42%), WMA-dobutamine in 56 (26%), microvas-
ular obstruction in 67 (31%), and transmural ne-
With and Without MACE
With MACE
(n  21)
No MACE
(n  193) p Value
58 14 57 11 0.9
16 (76) 164 (85) 0.3
4 (19) 31 (16) 0.8
10 (48) 77 (40) 0.5
9 (43) 70 (36) 0.6
14 (67) 121 (63) 0.8
18 (86) 105 (54) 0.005
86 22 80 21 0.2
120 25 125 24 0.4
1 1 1 0.3 0.2
248 176 239 181 0.8
4 2 3 2 0.02
97 59 69 71 0.06
149 75 132 58 0.3
1 0.4 1 1 1
72 19 73 25 0.9
10 (48) 46 (24) 0.03
7 (33) 44 (23) 0.3
9 (43) 80 (41) 0.8
18 (90) 180 (93) 0.9
11 (52) 151 (78) 0.01
12 (57) 113 (59) 0.9
6 (30) 79 (41) 0.6
11 (55) 127 (66) 0.6
15 (70) 113 (58) 0.3
16 (80) 156 (81) 0.8
7 (33) 18 (9) 0.004
dverse cardiac events; TIMI  Thrombolysis In Myocardial Infarction.ntsrosis was detected in 74 (35%).
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839In the univariate analyses, the presence of abnor-
al CMR indexes soon after infarction was associ-
ted with a higher probability of MACE during
ollow-up (Fig. 2, Table 3).
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Figure 2. CMR Indexes and MACE Rate
Kaplan-Meier survival distributions without major adverse cardiac e
cardiac magnetic resonance (CMR) indexes soon after infarction. WM
Table 2. Prognostic Value of CMR Data to Predict MACE
Study Group
(n  214)
With
(n 
Ejection fraction (%) 51 14 39
Ejection fraction-dobutamine (%) 56 14 46
End-diastolic volume index (ml/m2) 80 26 87
End-systolic volume index (ml/m2) 41 23 55
Left ventricular mass (g/m2) 70 18 77
Infarct size (% of left ventricular mass) 31 15 44
CMR indexes
WMA (segments) 5 3 8
WMA-dobutamine (segments) 4 3 6
Microvascular obstruction (segments) 1 2 3
Transmural necrosis (segments) 4 3 7
Variables tested in the multivariate analysis: 1) variables displaying a p value  0.2
anterior descending artery, myocardial blush grade, and need for diuretic therapy;
hypertension, and diabetes; 3) all cardiac magnetic resonance (CMR) data displaye
CI  conﬁdence interval; WMA  wall motion abnormalities; WMA-dobutamidose dobutamine.The MACE, death/reinfarction, and heart
ailure rates depending on the presence or ab-
ence of abnormal CMR indexes are displayed in
able 3.
Su
rv
iv
al
 fr
ee
 o
f M
AC
E
 
         
 
 
 
 
Weeks
WMA-dobutamine
	

   

 
Su
rv
iv
al
 fr
ee
 o
f M
AC
E
 
         
 
 
 
 
Weeks
Transmural Necrosis
	
   
    
 
  
s (MACE) on the basis of the presence or absence of abnormal
wall motion abnormalities; WMA-dobutamine  WMA with low-
E No MACE
(n  193)
p
Value
Harrell’s C Statistic
[95% CI]
p
Value
Ind
P
Haz
[
52 13 0.001 0.75 [0.64–0.86] 0.001
5613 0.003 0.70 [0.56–0.84] 0.006
80 25 0.2 0.57 [0.42–0.71] 0.3
39 21 0.002 0.68 [0.55–0.81] 0.006
69 16 0.04 0.58 [0.43–0.73] 0.2
13 15 0.001 0.76 [0.66–0.86] 0.001
5 3 0.001 0.75 [0.62–0.88] 0.001 1.29
4 3 0.004 0.68 [0.54–0.83] 0.01
1 2 0.001 0.66 [0.53–0.80] 0.01
3 3 0.001 0.79 [0.69–0.89] 0.001 1.30
ble 1: anterior infarction, heart rate, Killip class, TIMI risk score, peak troponin I, culprit
er variables that have previously been shown to be associated with adverse cardiov
Table 2. Hazard ratios of the 2 independent predictors are expressed as “per each se
WMA with low-dose dobutamine; other abbreviations as in Table 1.vent
A MAC
21)
ependent
redictors
ard Ratio
95% CI]
p
Value
13
14
29
28
29
13
4 [1.11–1.49] 0.001
4
3
3 [1.12–1.51] 0.001
in Ta lesion in the proximal left
2) oth ascular risks: age, male sex,
d in gment increase.”
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840ULTIVARIATE ANALYSIS. In a comprehensive
ultivariate analysis, the only variables indepen-
ently related to the MACE rate were WMA (HR:
.29, 95% CI: 1.11 to 1.49/segment, p  0.001)
nd the extent of transmural necrosis (HR: 1.30,
5% CI: 1.12 to 1.51/segment, p 0.001). Vari-
bles tested in the multivariate analysis area shown
t the foot of Table 2.
ombined analysis. A combined analysis of the vari-
bles independently associated with prognosis—
amely, WMA and the extent of transmural necro-
is—was carried out.
In the univariate analysis, the presence of trans-
ural necrosis in 4 segments increased the prob-
bility of cardiac events during follow-up in patients
ith WMA in 5 segments and in those with
MA in 5 segments (Fig. 3).
In the multivariate analysis, the extent of trans-
ural necrosis independently increased the risk of
ACE both in patients with WMA in 5 seg-
ents (HR: 1.35, 95% CI: 1.02 to 1.78/segment,
 0.04) and in those with WMA in5 segments
HR: 1.31, 95% CI: 1.10 to 1.55/segment, p 
.002).
Therefore, the extent of transmural necrosis
fforded prognostic information to predict
ACE regardless of the state of WMA (p for
nteraction between WMA and transmural ne-
rosis to predict MACE  0.8).
I S C U S S I O N
he main finding of the present study is that a
omprehensive CMR assessment allows for risk
Table 3. MACE, Death/Reinfarction, and Readmission for Heart
Abnormal CMR Indexes
MACE
WMA in 0–5 segments (n  125) 3%
WMA in 5 segments (n  89) 19%
p value 0.001
WMA-dobutamine in 0–5 segments (n  158) 6%
WMA-dobutamine in 5 segments (n  56) 20%
p value 0.001
Without microvascular obstruction (n  147) 6%
With microvascular obstruction (n  67) 18%
p value 0.001
Transmural necrosis in 0–4 segments (n  140) 3%
Transmural necrosis in 4 segments (n  74) 23%
p value 0.001
Abbreviations as in Tables 1 and 2.tratification soon after STEMI. The WMA andhe extent of transmural necrosis provide the most
elevant prognostic information.
In STEMI patients, recent recommendations
arrant an aggressive approach to re-establish cor-
nary flow (1,9). In this scenario myocardial isch-
mia in the infarcted area is eliminated, and the
linical profile of patients (1) along with the residual
ystolic function (17) emerge as the strongest prog-
ostic factors.
CMR allows for a simultaneous state-of-the-art
ssessment of a variety of indexes and is the only
maging technique that permits a reliable quantifi-
ation of the extent of transmural necrosis (3).
hether CMR indexes afford prognostic informa-
ion beyond that obtainable by means of echocar-
iography is unclear.
0
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10
15
20
25
30
WMA 0-5 segments
p=0.1
2% (2/107)
%
 M
AC
E
11% (2/18)
WMA >5 segments
p=0.01
6% (2/33)
27% (15/56)
Transmural necrosis 0-4 segments
Transmural necrosis >4 segments
Figure 3. MACE Rate According to the Extents of WMA and
Transmural Necrosis
When both WMA at rest and transmural necrosis were absent,
the MACE rate was very low; it was intermediate when only 1
index was abnormal and high when both indexes were altered.
re Rates Depending on the Presence or Absence of
Death and/or Reinfarction Heart Failure
3% 0%
7% 12%
0.2 0.001
2% 4%
11% 9%
0.02 0.1
4% 2%
6% 12%
0.4 0.005
2% 1%
9% 14%
0.02 0.001FailuAbbreviations as in Figure 2.
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841Due to the speedy incorporation of CMR into
aily practice for diagnostic purposes, its prognostic
alidation—a mandatory step in becoming an inte-
ral part of the management of patients (3)—is
ngoing. So far, data on the usefulness of individual
MR indexes for predicting risk soon after STEMI
atients are scarce (5,6,18), and whether they yield
rognostic information once adjusted for baseline
haracteristics and systolic function is uncertain.
his is a relevant issue because a comprehensive
pproach is possible but time-consuming, and
MR is not available in all institutions yet.
The present study represents the largest series of
atients so far dealing with the prognostic implica-
ions of CMR soon after STEMI.
MR indexes and prognosis after STEMI. We deter-
ined, along with systolic function, the extent of 3
dditional CMR indexes: contractile reserve, mi-
rovascular obstruction, and transmural necrosis.
ONTRACTILE RESERVE. Contractile reserve has
een widely used for predicting systolic recovery
fter STEMI (19). Owing to its high spatial reso-
ution, CMR represents the ideal technique for
erfectly quantifying the response to dobutamine.
ata regarding the prognostic usefulness of
obutamine-CMR in the context of myocardial
tunning are lacking. In this study we demonstrate
hat the analysis of the extent of WMA-
obutamine contributes prognostic information.
owever, from a practical point of view, assessment
f WMA-dobutamine should be carefully consid-
red because it is time-consuming and it does not
mprove the prognostic information provided by
ore easily obtainable indexes such as baseline
ystolic function and the extent of transmural
ecrosis.
ICROVASCULAR OBSTRUCTION. In STEMI pa-
ients, once coronary flow has been restored, micro-
ascular perfusion is of paramount importance (20).
e detected, in agreement with existing evidence
5,6), altered microvasculature in almost one-third
f the study group, exerting a deleterious effect on
atient outcome. Cardiac magnetic resonance-
erived microvascular obstruction appeared as an
ndependent predictor of events in a pioneering
tudy including a small group of patients (5) and in
more recent work that comprised a heterogeneous
eries of STEMI and non-STEMI patients (6).
In the present study, the strong prognostic infor-
ation provided by microvascular obstruction wasvercome by the extent of transmural necrosis. phese results are in agreement with recent data in
he context of chronic (7) and acute (18) STEMI
nd could be in part explained by the dynamic
hanges of microvascular perfusion over the first
ays and weeks after infarction (11,14). Conversely,
e have previously demonstrated that, in compari-
on with the other CMR indexes, the extent of
ransmural necrosis displays a more stable course
14), strengthening its ability to predict late systolic
unction (18) and prognosis since the acute phase.
RANSMURAL NECROSIS. In the context of recent
TEMI, we detected striking differences in terms
f MACE rate when comparing patients with (5 or
ore segments) and without (0 to 4) a large extent
f transmural necrosis: 23% versus 3% (Fig. 2).
oreover, this parameter added independent prog-
ostic information even after adjustment for well-
stablished prognostic markers such as clinical char-
cteristics, ECG, troponin I, angiography-derived
erfusion variables, ejection fraction, left ventricular
olumes, and all CMR indexes. The same trend was
bserved both in patients with and without large
MA (Fig. 3), confirming the independent prog-
ostic value of the extent of transmural necrosis
oon after STEMI beyond systolic function.
Systolic function has been traditionally consid-
red the main prognostic factor after STEMI
1,17). Dysfunctional segments might improve in
he weeks and months after reperfusion (2), exert-
ng a decisive influence on patient outcome (1).
ecovery of hypokinetic areas mainly depends on
he extent of transmural necrosis (2,13), and CMR
s currently the gold standard tool for assessing this
henomenon (3). This probably explains why, in
ur study, this was the only index that afforded
ndependent information along with WMA.
tudy limitations. We detected a small number of
linical events during follow-up that could be due
o the wide use of percutaneous revascularization
uring admission as well as to the exclusion of
atients at the highest risk, those with events and
ith severe clinical instability in acute phase.
his could have an effect on our results, especially
ith respect to the multivariable analysis. The
uantitative detection of “gray areas” (with inter-
ediate signal intensity between remote and
nfarcted myocardium) has been previously re-
ated to prognosis in a series of patients with
schemic heart disease with different characteris-
ics from ours (21); we did not carry out this
nalysis, which could have been helpful in im-
roving the risk stratification process.
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MR imaging allows for a complete characteriza-
ion of patients soon after STEMI. Our results
ndicate that, of the variety of indexes obtainable
ith CMR, baseline systolic function and the ex-
ent of transmural necrosis provide the most rele-
ant prognostic information. Systolic function is the
ornerstone of post-infarction risk stratification, but
t can be determined with more accessible methods
uch as echocardiography. Currently, CMR is thetricular function and volumes to pre- 2634–53.f the extent of transmural necrosis. Its simplicity
nd robustness make this index a promising tool not
nly for diagnostic but also for prognostic purposes.
owever, further studies including a larger number
f patients and a wider clinical spectrum are needed
efore recommending the inclusion of CMR for
outine risk stratification soon after STEMI.
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